RARE
Ultragenyx Pharm (RARE)
NASDAQ
$14.30-$0.002 (-0.01%)
Price as of Sep 11, 2026 7:56 PM EDT
  • $1.4B
    Market Cap
  • -52.82%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 37
Valuation
RARE
vs History
vs S&P 500
Profitability
-0
Growth
-1
Low Earnings Volatility
3

Momentum Score

Score: 3
Valuation
RARE
vs History
vs S&P 500
3-Month Momentum
17.86%
12-Month Momentum
-13.99%
3-Month Risk Adjusted Momentum
78.16%
12-Month Risk Adjusted Momentum
-21.00%

True Yield

N/A
Valuation
RARE
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.08%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 44
Valuation
RARE
vs History
vs S&P 500
Ohlson's O-Score
6